Five Themes For Korean Biopharma In 2025

US Approvals, New Modalities, Obesity

 
• By Jung Won Shin

Scrip picks five key themes that dominated biopharma developments in 2024 and look set to continue to influence the industry throughout this year.

Scrip Perspectives - new chapter
Korean Industry Entering A New Growth Chapter Despite Political Uncertainties (Shutterstock)

More from South Korea

More from Scrip Perspectives